A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

Published:2013-04-30 Issue:1 Volume:48 Page:76-84
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Howard James F.¹,Barohn Richard J.²,Cutter Gary R.³,Freimer Miriam⁴,Juel Vern C.⁵,Mozaffar Tahseen⁶,Mellion Michelle L.⁷,Benatar Michael G.⁸,Farrugia Maria Elena⁹,Wang Jing Jing¹⁰,Malhotra Suneil S.¹⁰,Kissel John T.⁴,

Affiliation:

1. Department of Neurology; University of North Carolina; 2200 Physicians Office Building, CB 7025, 170 Manning Drive, Chapel Hill North Carolina 27599-7025 USA

2. Department of Neurology; University of Kansas; Lawrence Kansas USA

3. Department of Biostatistics; University of Alabama at Birmingham School of Public Health; Birmingham Alabama USA

4. Department of Neurology; Ohio State University; Columbus Ohio USA

5. Department of Medicine; Duke University; Durham North Carolina USA

6. ALS and Neuromuscular Center; University of California; Irvine California USA

7. Department of Neurology; Warren Alpert Medical School of Brown University; Providence Rhode Island USA

8. Department of Neurology; University of Miami; Miami Florida USA

9. Department of Neurology; Institute of Neurological Sciences; Glasgow UK

10. Clinical Research and Global Medical Affairs Departments; Alexion Pharmaceuticals; Cheshire Connecticut USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.23839/fullpdf

Reference30 articles.

1. Disorders of Neuromuscular Transmission

2. Clinical evaluation and management of myasthenia gravis;Keesey;Muscle Nerve,2004

3. Current and future standards in treatment of myasthenia gravis;Gold;Neurotherapeutics,2008

4. Lifetime course of myasthenia gravis;Grob;Muscle Nerve,2008

5. Myasthenia gravis: past, present, and future;Conti-Fine;J Clin Invest,2006

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms;Drug Discovery Today;2024-09

2. Integrated Applied Clinical Pharmacology in the Advancement of Rare and Ultra‐Rare Disease Therapeutics;Clinical Pharmacology & Therapeutics;2024-07-22

3. Myasthenia gravis – Update;Fortschritte der Neurologie · Psychiatrie;2024-04

4. Promising therapies for the treatment of myasthenia gravis;Expert Opinion on Pharmacotherapy;2024-03-03

5. The Efficacy and Safety of Different Targeted Drugs for the Treatment of Generalized Myasthenia Gravis: A Systematic Review and Bayesian Network Meta-analysis;CNS Drugs;2024-02